Randeep Guleria ▸ Facts ▸ Comments ▸ News ▸ Videos
Controversy of 'comparing vaccines' laid to rest: AIIMS Director on PM taking COVID shot
Credit: ANI Duration: 01:26Published
Dr Randeep Guleria receives 2nd dose of COVID-19 vaccine
Credit: ANI Duration: 01:25Published
Harsh Vardhan inaugurates Burn and Plastic Surgery block at Delhi’s AIIMS
Credit: HT Digital Content Duration: 02:21Published
Watch: AIIMS Director Randeep Guleria gets COVID-19 vaccine shot
Credit: ANI Duration: 01:17Published
You Might Like
New Covid-19 strains not 'more infectious', need to aggressively monitor situation: AIIMS Director Randeep GuleriaGuleria also said that there was a need to aggressively study the mutations of the Covid-19 virus. "Currently we have vaccines with efficacy of 70 per cent , 80 per cent, 90 per cent so even if there..
Herd immunity difficult to achieve: AIIMS director Randeep Guleria
Covid-19 vaccine maybe available in open market by year end, says AIIMS directorCoronavirus vaccines might be available in the open market by end of the year only when prime targeted people are covered and there is an equivalence of supply and demand, said Dr Randeep Guleria,..
COVID-19: THIS man becomes first person in India to receive coronavirus vaccineA sanitation worker became the first person in India to receive COVID-19 vaccine jab at AIIMS, New Delhi. The worker identified as Manish Kumar received the vaccine in the presence of Union Health..
From eligibility to side-effects, all your questions about COVID-19 vaccination answeredHere are all the queries answered by All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria.
2 virus mutations per month, no need for alarm: GuleriaDelhi AIIMS director Dr Randeep Guleria, said here on Friday that the coronavirus had undergone several mutations, an average of two per month, and that new strains should not warrant unnecessary..
Hopeful India will get Covid-19 vaccine nod by Dec end or early Jan: AIIMS director Randeep Guleria
Covid-19: Centre rushes high-level teams to 4 states to strengthen surveillance, testingThe Centre has rushed high-level teams to Haryana, Rajasthan, Gujarat and Manipur where they will visit districts reporting high number of Covid-19 cases and support the state's efforts towards..
Is India heading towards another lockdown from December 1? PIB clarifiesRecently, AIIMS Delhi director Randeep Guleria warned that the second wave of coronavirus in India has begun. People should not leave the house unless absolutely necessary, he said
Keeping Pfizer's Covid-19 vaccine at low temperatures will be challenging for India, others: AIIMS DirectorDr Randeep Guleria, Director, All India Institute of Medical Sciences Delhi (AIIMS), Delhi on Wednesday said the results of Pfizer's Covid-19 vaccine phase III trials are very encouraging but..
Disease burden might increase drastically if Covid-19 & air pollution get combined: AIIMS director Guleria
Common people have to wait till 2022 to get COVID-19 vaccine: AIIMS Director Dr Randeep GuleriaDr Guleria reiterated the importance of maintaining social distancing and wearing masks. "One person not taking the precautions can lead to a superspreading event," he said.
Weeks after discharge, Amit Shah re-admitted to AIIMSShah is getting treatment under Dr Randeep Guleria, director of AIIMS and his condition is said to be stable.
Amit Shah re-admitted to AIIMS weeks after discharge, condition stableShah is getting treatment under Dr Randeep Guleria, director of AIIMS and his condition is said to be stable.
Randeep Guleria-led AIIMS team likely to visit Medanta to oversee Amit Shah's Covid-19 treatmentA team of doctors led by AIIMS Director Dr Randeep Guleria is likely to visit Medanta hospital in Gurugram, where Union home minister Amit Shah has been admitted for Covid-19 treatment, sources at..
AIIMS director on Covid vaccine human trials, community spread: Key pointsThe clinical trial of the indigenously developed Covid-19 vaccine candidate Covaxin will be conducted in three phases, AIIMS director Randeep Guleria told reporters on Monday. Guleria, addressing the..
India vulnerable to second wave of coronavirus: AIIMS directorAIIMS director Randeep Guleria said India is also vulnerable to second wave of coronavirus and people should continue to follow social distancing, wearing mask and other precautions, after cases begin..
Managing hotspots is key to ‘blunted peak’: AIIMS directorAIIMS director Dr Randeep Guleria said on Thursday that if the Covid-19 hotspots are managed properly, India may witness a ‘blunted peak’. “It means that we will not have huge spike as has been..
Covid-19 likely to peak in India in June-July: AIIMS directorAs per the modeling data and the way India's Covid-19 cases are increasing, it is likely that peak can come in June and July, said AIIMS-Delhi Director Dr Randeep Guleria on Thursday. "But there are..
Stigma attached to Covid can cause more deaths: AIIMS headStigmatising of Covid-19 patients and their families is resulting in cases turning up late at hospitals, with heightened breathlessness, and this could mean increased morbidity and mortality, Dr..
Stigma attached to COVID-19 stopping many people from coming forward to get tested and treated: AIIMS DirectorAIIMS Director Prof Randeep Guleria said the tendency to not come forward due to stigma is leading not only to huge mental agonies and problems but also higher morbidity and mortality.
Some community spread in hotspots: AIIMS chiefThere may be some community spread of Covid-19 in hotspots and these areas need to be monitored closely to prevent community transmission of the virus, AIIMS director Dr Randeep Guleria said on Monday...
CJI rules out complete shutdown of SC amid coronavirus threatChief Justice of India S A Bobde on Sunday made it clear that there cannot be a "complete shutdown" of courts due the novel coronavirus pandemic. The CJI held a meeting with four apex court judges, bar..